LAWRENCE, Mass., Jan. 28, 2015 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative
dialysis products, today announced plans to release its financial
results for the fourth quarter and full year ended December 31, 2014, on Thursday, February 26, 2015, before the opening
of the financial markets.
NxStage will also host a conference call at 9:00 a.m. Eastern Time on Thursday, February 26, 2015 to discuss its fourth
quarter and full year financial results. To listen to the
conference call, please dial 877-392-9886 (domestic) or
707-287-9329 (international). The call will also be webcast
LIVE and can be accessed via the investor relations section of the
Company's website at http://ir.nxstage.com.
A replay of the conference call will be available two hours
after the completion of the call through March 6, 2015. To access the replay, dial
855-859-2056 (domestic) or 404-537-3406 (international) and
reference conference ID 65800439. An online archive of the
conference call can be accessed via the investor relations section
of the Company's website at http://ir.nxstage.com.
About NxStage
NxStage Medical, Inc. (Nasdaq: NXTM) is
a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. For more
information on NxStage and its products, please visit the Company's
website at www.nxstage.com.
Forward-Looking Statements
This Release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements
contained in this Release that are not clearly historical in nature
are forward-looking, and the words "anticipate", "believe",
"expect", "estimate", "plan" and similar expressions are generally
intended to identify forward- looking statements. The
forward-looking statements in this Release include NxStage's plan
to release its financial results on February
26, 2015. Actual results may differ materially from those
indicated by these forward-looking statements as a result of
various important factors including, but not limited to, unexpected
difficulty in closing the Company's financial books for the quarter
and other factors that are discussed in NxStage's Quarterly Report
on Form 10-Q for the quarter ended September
30, 2014 filed with the SEC. NxStage is under no obligation
to (and expressly disclaims any such obligation to) update or alter
its forward-looking statements, whether as a result of new
information, future events or otherwise.
Contact: Kristen K. Sheppard,
Esq.
VP, Investor Relations
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-to-report-fourth-quarter-and-full-year-2014-financial-results-300025804.html
SOURCE NxStage Medical, Inc.